Prevalence of metabolic syndrome in patients with schizophrenia in India

Psychiatry Research

Volumn 200, Issue 2-3, 2012, Pages 1035-1037

  Grover, Sandeep ^a   Aggarwal, Munish ^a   Dutt, Alakananda ^a   Chakrabarti, Subho ^a   Avasthi, Ajit ^a   Kulhara, Parmanand ^a   Somaiya, Mansi ^a   Malhotra, Nidhi ^a   Chauhan, Nidhi ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Metabolic syndrome; Prevalence; Schizophrenia

Indexed keywords

CLOZAPINE; GLUCOSE; OLANZAPINE; RISPERIDONE; TRIFLUOPERAZINE;

ADULT; AGE; ARTICLE; BODY MASS; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE DURATION; EMPLOYMENT STATUS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; SCHIZOPHRENIA; SEX DIFFERENCE; URBAN AREA; WAIST CIRCUMFERENCE;

EID: 84872399343     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2012.03.043     Document Type: Article

References (19)

1. Alberti K.G., Zimmet P., Shaw J. IDF epidemiology task force consensus group. The metabolic syndrome-a new worldwide definition. Lancet 2005, 366:1059-1062.
2. Chang H.H., Chou C.H., Chen P.S., Gean P.W., Huang H.C., Lin C.Y.-, Yang Y.K., Lu R.B. High prevalence of metabolic disturbances in patients with bipolar disorder in Taiwan. Journal of Affective Disorders 2009, 117(1-2):124-129.
3. Correll C.U., Frederickson A.M., Kane J.M., Manu P. Metabolic syndrome and the risk of coronary heart disease in 367 patients treated with second-generation antipsychotic drugs. Journal of Clinical Psychiatry 2006, 67(4):575-583.
4. Correll C.U., Frederickson A.M., Kane J.M., Manu P. Does antipsychotic polypharmacy increase the risk formetabolic syndrome?. Schizophrenia Research 2007, 89(1-3):91-100.
5. De Hert M.A., van Winkel R., Van Eyck D., Hanssens L., Wampers M., Scheen A., Peuskens J. Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication. Schizophrenia Research 2006, 83(1):87-93.
6. NCEP ATP-III Expert Panel on Detection and Treatment of High Blood Cholesterol in Adults: executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Journal of the American Medical Association 2001, 285:2486-2497.
7. Grover S., Nebhinani N., Chakrabarti S., Avasthi A., Kulhara P. Prevalence of metabolic syndrome in subjects receiving Clozapine: a study from India. Indian Journal of Pharmacology 2011, 43:591-595.
8. Huang M.C., Lu M.L., Tsai C.J., Chen P.Y., Chiu C.C., Jian D.L., Lin K.M., Chen C.H. Prevalence of metabolic syndrome among patients with schizophrenia or schizoaffective disorder in Taiwan. Acta Psychiatrica Scandinavica 2009, 120(4):274-280.
9. Lee N.Y., Kima S.H., Jung D.C., Kima E.Y., Yu H.Y., Sung K.H., Kang U.G., Ahn Y.M., Kim Y.S. The prevalence of metabolic syndrome in Korean patients with schizophrenia receiving a monotherapy with aripiprazole, olanzapine or risperidone. Progress in Neuropsychopharmacology and Biological Psychiatry 2011, 35(5):1273-1278.
10. McEvoy J.P., Mayer J.M., Goff D.C., Nasrallah H.A., Davis S.M., Sullivan L., Meltzer H.Y., Hsiao J., Scott Stroup T., Lieberman J.A. Prevalence of metabolic syndrome in patients with schizophrenia: baseline results from the clinical antipsychotic trials of intervention effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. Schizophrenia Research 2005, 80:19-32.
11. Meyer J.M., Stahl S.M. The metabolic syndrome and schizophrenia. Acta Psychiatrica Scandinavica 2009, 119(1):4-14.
12. Misra A., Wasir J.S., Pandey R.M. An evaluation of candidate definitions of the metabolic syndrome in adult Asian Indians. Diabetes Care 2005, 28:398-403.
13. Padmavati R., McCreadie R.G., Tirupati S. Low prevalence of obesity and metabolicsyndrome in never-treated chronic schizophrenia. Schizophrenia Research 2010, 121:199-202.
14. Ravikiran M., Bhansali A., Ravikumar P., Bhansali S., Dutta P., Thakur J.S., Sachdeva N., Bhadada S., Walia R. Prevalence and risk factors of metabolic syndrome among Asian Indians: a community survey. Diabetes Research and Clinical Practice 2010, 89:181-188.
15. Saddichha S., Manjunatha N., Ameen S., Akhtar S. Diabetes and schizophrenia-effect of disease or drug? Results from a randomized, double-blind, controlled prospective study in first-episode schizophrenia. Acta Psychiatrica Scandinavica 2008, 117:342-347.
16. Saddichha S., Narayana M., Shahul A., Sayeed A. Metabolic syndrome in first episode schizophrenia-randomized double-blind controlled, short-term prospective study. Schizophrenia Research 2008, 101:266-272.
17. Tan C.E., Ma S., Wai D., Chew S.K., Tai E.S. Can we apply the National Cholesterol Education Program Adult Treatment Panel Definition of the metabolic syndrome to Asians?. Diabetes Care 2004, 27:s1182-s1186.
18. Tirupati S., Chua L.E. Body mass index as a screening test for metabolic syndrome in schizophrenia and schizoaffective disorders. Australasian Psychiatry 2007, 15(6):470-473.
19. World Health Organization The ICD-10 classification of mental and behavioural disorders-clinical descriptions and diagnostic guidelines 1992, WHO, Geneva.